Roche to Buy Maker of Fatty Liver Treatment 89bio for Up to $3.5 Billion The Wall Street Journal Roche to acquire liver drug developer 89bio for up to $3.5 billion Reuters RHHBY to Acquire 89bio for $3.5B, Add Late-Stage MASH Drug to Pipeline Yahoo Finance Roche to buy metabolic biotech 89bio for up to $3.5B Axios Roche enters into a definitive merger agreement to …
Read More »